245 results on '"Ganguly, Shuvadeep"'
Search Results
52. Hemophagocytic Lymphohistiocytosis Associated with Visceral Leishmaniasis: Varied Presentation
53. Cost‐effectiveness analysis of aprepitant‐based anti‐emetic regimen for children receiving highly emetogenic chemotherapy: Individual patient data analysis of a randomized trial
54. Long‐term effects of chemotherapy and radiation received during early childhood on the developing dentition of pediatric cancer patients
55. Decoding mitochondrial genes in pediatric AML and development of a novel prognostic mitochondrial gene signature
56. Determinants and impact of diagnostic interval in bone sarcomas: A retrospective cohort study.
57. Long‐term effects of chemotherapy and radiation received during early childhood on the developing dentition of pediatric cancer patients.
58. Mitochondrial biogenesis gene POLG correlates with outcome in pediatric acute myeloid leukemia
59. Neoadjuvant nivolumab with chemotherapy in resectable lung cancer
60. Pembrolizumab as adjuvant therapy in melanoma
61. Authors' reply to Kakoti and Laskar
62. Secondary cytoreductive surgery in recurrent ovarian carcinoma
63. Trastuzumab deruxtecan in HER2-mutant non-small-cell lung cancer
64. Profile and outcome of advanced malignant melanoma in India: Need for cost-effective innovations
65. Relatlimab and nivolumab in untreated advanced melanoma
66. Overall survival with brentuximab vedotin in advanced Hodgkin lymphoma
67. Day 14 bone marrow response assessment in acute myeloid leukemia: Should we discontinue?
68. Trastuzumab deruxtecan in HER2-low breast cancer
69. Brentuximab vedotin in pediatric Hodgkin lymphoma
70. Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer
71. Overall survival with ribociclib and letrozole in advanced postmenopausal hormone receptor–positive breast cancer
72. Triplet therapy, transplantation, and maintenance until progression in multiple myeloma
73. Neoadjuvant cemiplimab for stages II to IV cutaneous squamous cell carcinoma
74. Mitochondrial complex II and V activity is enhanced in pediatric acute myeloid leukemia
75. Late effects in pediatric Hodgkin lymphoma survivors after uniform treatment with ABVD with or without radiotherapy
76. Pembrolizumab monotherapy in advanced triple-negative breast cancer
77. PGC1A driven enhanced mitochondrial DNA copy number predicts outcome in pediatric acute myeloid leukemia
78. Extending adjuvant endocrine therapy in hormone receptor-positive breast cancer: An Indian perspective
79. Pembrolizumab in recurrent or metastatic cervical cancer
80. Cabozantinib for radioiodine-refractory progressive differentiated thyroid cancer
81. Adjuvant olaparib in germline BRCA-mutated breast cancer – Standard of care for all?
82. Addition of aprepitant improves acute emesis control in children and adolescents receiving induction chemotherapy for acute myeloid leukaemia: a randomised, open-label trial
83. Teleconsultations and Shared Care in Pediatric Oncology During COVID-19
84. HL-300: Long-Term Toxicity of ABVD in Paediatric Hodgkin Lymphoma: A Prospective Longitudinal Cohort Study
85. Traditional and complementary medicine during COVID ‐19 pandemic
86. Outpatient ADE (cytarabine, daunorubicin, and etoposide) is feasible and effective for the first relapse of pediatric acute myeloid leukemia: A prospective, phase II study
87. Real-world Experience of Imatinib in Pediatric Chronic Phase Chronic Myeloid Leukemia: A Single-center Experience From India
88. Measuring quality of life in Indian children with cancer: Addressing an unmet need
89. Overall survival with osimertinib in resected EGFR-mutated non-small-cell lung cancer.
90. Characterization of bone marrow involvement in pediatric hodgkin lymphoma using 18F-FDG-PET/CT and its comparison with blind bone marrow biopsy
91. Characterization Of Bone Marrow Involvement In Pediatric Hodgkin Lymphoma Using 18f-Fdg Pet/Ct And Its Comparison With Blind Bone Marrow Biopsy
92. Fever of Unknown Origin: An Unusual Presentation of Kikuchi-Fujimoto Disease
93. Triplet therapy, transplantation, and maintenance until progression in multiple myeloma.
94. Brentuximab vedotin in pediatric Hodgkin lymphoma.
95. Pembrolizumab as adjuvant therapy in melanoma.
96. Overall survival with brentuximab vedotin in advanced Hodgkin lymphoma.
97. Prevalence of low HER2 expression in breast cancer patients: An Indian experience.
98. Hemophagocytic Lymphohistiocytosis Associated with Visceral Leishmaniasis: Varied Presentation
99. Isolated native tricuspid valve endocarditis presenting as puo in a young adult male without any risk factors
100. Overall survival with ribociclib and letrozole in advanced postmenopausal hormone receptor-positive breast cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.